ArticleWorld journal of clinical pediatrics2026
Systemic outcomes of anesthesia method in anti-vascular endothelial growth factor therapy for retinopathy of prematurity: General
Article in World journal of clinical pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe type of anesthesia needed while performing an anti-vascular endothelial growth factor (VEGF) injection in preterm infants with retinopathy of prematurity is not well standardized. In Oman, general anesthesia (GA) remained the first choice by ophthalmologists treating retinopathy of prematurity (ROP) infants at the time of starting the study. Short-term systemic outcome in GA
aimTo analyze the short-term systemic outcomes of GA in infants undergoing anti-VEGF injections
methodsThis is an observational study with historical comparison. Estimated sample size is 36 (18 in each group), based on the anticipated rate of difference in the outcome between the two cohorts of 50%, type I error (α) probability of 5%, power of 80%, and the allocation ratio of 1:1. The statistical test considered was Fisher's exact test. The calculation was done using the G*Power version 3.1.9.2. Infants were from two main tertiary hospitals in Oman.
resultsA total of 36 infants with retinopathy of prematurity were enrolled in the study: 18 in the retrospective (GA) cohort and 18 in the prospective (TA) cohort. The Primary outcome-the need for oxygen and/or respiratory support during the 48 hours post-procedure-occurred in 27.8% of the GA cohort, as compared to none of TA cohort (
conclusionTA is associated with a reduced need for oxygen and/or respiratory support within 48 hours post-procedure, and better performance in duration, cost, and surgeon preference compared to GA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.